Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.
about
Uncovering the role of brain-derived neurotrophic factor/tyrosine kinase receptor B signaling in head and neck malignancies.Dual inhibition of BDNF/TrkB and autophagy: a promising therapeutic approach for colorectal cancerNeurotrophin Trk Receptors: New Targets for Cancer Therapy.Combined Treatments with a Retinoid Receptor Agonist and Epigenetic Modulators in Human Neuroblastoma Cells.Targeting tyrosine receptor kinase B in gliomas.Gene expression changes associated with chemotherapy resistance in Ewing sarcoma cells.
P2860
Trk inhibition reduces cell proliferation and potentiates the effects of chemotherapeutic agents in Ewing sarcoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 26 April 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Trk inhibition reduces cell pr ...... eutic agents in Ewing sarcoma.
@en
Trk inhibition reduces cell pr ...... eutic agents in Ewing sarcoma.
@nl
type
label
Trk inhibition reduces cell pr ...... eutic agents in Ewing sarcoma.
@en
Trk inhibition reduces cell pr ...... eutic agents in Ewing sarcoma.
@nl
prefLabel
Trk inhibition reduces cell pr ...... eutic agents in Ewing sarcoma.
@en
Trk inhibition reduces cell pr ...... eutic agents in Ewing sarcoma.
@nl
P2093
P2860
P356
P1433
P1476
Trk inhibition reduces cell pr ...... peutic agents in Ewing sarcoma
@en
P2093
Algemir Lunardi Brunetto
Amanda da Rocha
André Tesainer Brunetto
Bárbara Kunzler Souza
Caroline Brunetto de Farias
Lauro José Gregianin
Luís Fernando da Rosa Rivero
Marco Aurélio Silva Filho
Michel Pinheiro Dos Santos
Patrícia Luciana da Costa Lopez
P2860
P304
34860-34880
P356
10.18632/ONCOTARGET.8992
P407
P50
P577
2016-06-01T00:00:00Z